
Globus Medical, Inc.
GMEDNYSEHealthcareMedical - Devices
Previous close
$86.91
+$1.24 · +1.45%
GMED company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
86
Deep Value
Momentum
37
Weakening
Sentiment
79
Bullish
Risk resilience
57
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteGlobus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Keith W. Pfeil
- Listed since
- Aug 3, 2012
- Employees
- 6,000
Market position
Day range
Current $86.91
52-week range
Current $86.91
- Open
- $85.64
- Previous close
- $85.67
- Volume
- 651.82K
- 0.39× average
- Average volume
- 1.67M
- Average daily volume
- Market cap
- 11.72B USD
- Beta
- 0.95
- Market reference 1
- 50-day average
- $80.6208
- +7.80% above average
- 200-day average
- $85.7055
- +1.41% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- 21.89×
- P/B (TTM)
- 2.47×
- P/S (TTM)
- 3.73×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 68.55%
- Operating margin
- 20.75%
- Net margin
- 17.03%
Financial health
- Debt / equity
- 0.02×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.94B USD | 2.52B USD | 1.57B USD | 1.02B USD | 958.1M USD |
| Cost of goods sold | 957.8M USD | 1.04B USD | 548.17M USD | 263.73M USD | 239.22M USD |
| Gross profit | 1.98B USD | 1.48B USD | 1.02B USD | 759.12M USD | 718.88M USD |
| Research and development | 185M USD | 163.75M USD | 124.01M USD | 73.02M USD | 97.35M USD |
| Selling, general, and administrative | 1.32B USD | 981.05M USD | 643.41M USD | 432.12M USD | 408.15M USD |
| Operating expenses | 1.5B USD | 1.32B USD | 887.16M USD | 531.17M USD | 546.93M USD |
| Interest income | 7.14M USD | — | 20.13M USD | 14.23M USD | 9.3M USD |
| Interest expense | — | 4.19M USD | — | — | — |
| Depreciation and amortization | 120M USD | 254.02M USD | 144.73M USD | 68.25M USD | 69.87M USD |
| Operating income | 479.8M USD | 165.99M USD | 133.14M USD | 227.95M USD | 171.95M USD |
| Net income | 537.9M USD | 102.98M USD | 122.87M USD | 190.17M USD | 149.19M USD |
Company facts updated Aug 24, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$98.88
13.77% upsideRating distribution
36 ratingsGMED news
GMED peers
ETFs holding GMED
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Mid-Cap ETFIJH333.65M0.26%125.92B USD0.05%$76.77+0.52%
Vanguard Morningstar Total Stock Market ETFVTI284.18M0.01%2.3T USD0.03%$378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB205.02M0.11%183.4B USD0.03%$304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK118.73M0.27%43.8B USD0.05%$358.65+0.70%
Vanguard Extended Market ETFVXF102.76M0.11%93.7B USD0.05%$245.53+0.82%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY71.09M0.27%26.72B USD0.23%$699.6+0.48%
iShares S&P Mid-Cap 400 Growth ETFIJK56.25M0.50%10.95B USD0.16%$115.45+0.37%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD50.41M0.27%18.77B USD0.03%$67.27+0.52%
iShares Core S&P Mid-Cap ETFIJH- Market value
- 333.65M
- Weight
- 0.26%
- AUM
- 125.92B USD
- Expense ratio
- 0.05%
- Price / 1D
- $76.77+0.52%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 284.18M
- Weight
- 0.01%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 205.02M
- Weight
- 0.11%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK- Market value
- 118.73M
- Weight
- 0.27%
- AUM
- 43.8B USD
- Expense ratio
- 0.05%
- Price / 1D
- $358.65+0.70%
Vanguard Extended Market ETFVXF- Market value
- 102.76M
- Weight
- 0.11%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY- Market value
- 71.09M
- Weight
- 0.27%
- AUM
- 26.72B USD
- Expense ratio
- 0.23%
- Price / 1D
- $699.6+0.48%
iShares S&P Mid-Cap 400 Growth ETFIJK- Market value
- 56.25M
- Weight
- 0.50%
- AUM
- 10.95B USD
- Expense ratio
- 0.16%
- Price / 1D
- $115.45+0.37%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD- Market value
- 50.41M
- Weight
- 0.27%
- AUM
- 18.77B USD
- Expense ratio
- 0.03%
- Price / 1D
- $67.27+0.52%
Continue in GoAI
Research GMEDresearch.disclaimer











